Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Ingenta (ING) by Steve Moore in ShareProphets
- Avoid Videndum (VID) by Steve Moore in ShareProphets
- Watch Funding Circle Holdings (FCH) by Mark Hartley in The Motley Fool
- Sell Dr. Martens (DOCS) by Steve Moore in ShareProphets
- Hold Persimmon (PSN) by Berenberg
- Buy Atalaya Mining (ATYM) by Berenberg
- Buy Alfa Financial Software Holdings (ALFA) by Berenberg
- Avoid British American Tobacco (BATS) by Royston Wild in The Motley Fool
- Avoid BP (BP.) by Royston Wild in The Motley Fool
- Avoid BT Group (BT.A) by Royston Wild in The Motley Fool
- Buy RS Group (RS1) by John Ficenec in The Times - Tempus
- Buy Johnson Matthey (JMAT) by Jefferies
- Hold Zigup (ZIG) by Jefferies
- Watch Solid State (SOLI) by Steve Moore in ShareProphets
- Buy Forterra (FORT) by Jefferies
- Buy Conduit Holdings Limited Com Shs (DI) (CRE) by Jefferies
- Buy Intermediate Capital Group (ICG) by Jefferies
- Buy Rolls-Royce Holdings (RR.) by Jefferies
- Buy Persimmon (PSN) by Jefferies
- Avoid Forterra (FORT) by Steve Moore in ShareProphets
Shield Therapeutics (STX) Share Price
Health Care Sector
NOTE: This is based on 62 open tips for Shield Therapeutics (STX)
| Latest Bid : 3.10p | Latest Ask : 3.20p |
| High Today : 3.40p | Low Today : 3.00p |
| This Years High : 12.20p | This Years Low : 3.00p |
| Volume : 1,478,866 | MKT Cap : £25.02M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Shield Therapeutics (STX) Overview
Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.Shield Therapeutics (STX) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2026-11-03 11:05:00 03/11/2026 | 8.57% |
| Buy | Peel Hunt | Premium Only | 2025-11-07 16:31:00 07/11/2025 | -53.28% |
| Buy | Peel Hunt | Premium Only | 2025-09-15 11:19:00 15/09/2025 | -60.98% |
| Sell | Tom Winnifrith | Premium Only | 2024-02-21 12:20:00 21/02/2024 | -10.34% |
| Buy | William Kay | Premium Only | 2023-09-29 00:05:00 29/09/2023 | -26.80% |
Shield Therapeutics (STX) Recent Short Position Updates
| Position | Date | |||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 3.10p | Latest Ask : 3.20p |
| High Today : 3.40p | Low Today : 3.00p |
| This Years High : 12.20p | This Years Low : 3.00p |
| Volume : 1,478,866 | MKT Cap : £25.02M |
Shield Therapeutics Overview
Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Shield Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2026-11-03 11:05:00 03/11/2026 | 8.57% |
| Buy | Peel Hunt | Premium Only | 2025-11-07 16:31:00 07/11/2025 | -53.28% |
| Buy | Peel Hunt | Premium Only | 2025-09-15 11:19:00 15/09/2025 | -60.98% |
| Sell | Tom Winnifrith | Premium Only | 2024-02-21 12:20:00 21/02/2024 | -10.34% |
| Buy | William Kay | Premium Only | 2023-09-29 00:05:00 29/09/2023 | -26.80% |